166 related articles for article (PubMed ID: 35579592)
1. Highlights in advanced prostate cancer from the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Clin Adv Hematol Oncol; 2022 Apr; 20 Suppl 8(4):1-24. PubMed ID: 35579592
[No Abstract] [Full Text] [Related]
2. Highlights in prostate cancer from the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Clin Adv Hematol Oncol; 2024 Apr; 22(3):112-113. PubMed ID: 38588269
[No Abstract] [Full Text] [Related]
3. Highlights in prostate cancer from the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Clin Adv Hematol Oncol; 2023 Apr; 21(4):199-201. PubMed ID: 37039728
[No Abstract] [Full Text] [Related]
4. Inside the 2015 ASCO Genitourinary Cancers Symposium.
Santoni M; Massari F; Iacovelli R; Ciccarese C; Verri E; Burattini L; Montironi R; Nolè F; Tortora G; Cascinu S
Future Oncol; 2015; 11(13):1859-62. PubMed ID: 26161923
[TBL] [Abstract][Full Text] [Related]
5. Highlights in advanced prostate cancer from the 2014 American Society of Clinical Oncology genitourinary cancers symposium: commentary.
George DJ
Clin Adv Hematol Oncol; 2014 Apr; 12(4 Suppl 11):12-6. PubMed ID: 24870260
[No Abstract] [Full Text] [Related]
6. Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Commentary.
Shore ND
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 5):17-9. PubMed ID: 27167847
[No Abstract] [Full Text] [Related]
7. Highlights in advanced prostate cancer from the 2013 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Clin Adv Hematol Oncol; 2013 Apr; 11(4 Suppl 7):1-22. PubMed ID: 23880604
[No Abstract] [Full Text] [Related]
8. Highlights from the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Clin Adv Hematol Oncol; 2022 Mar; 20(3):158-160. PubMed ID: 36607345
[No Abstract] [Full Text] [Related]
9. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Shen J; Prentice M; Pollock Y; Franca M; Kanesvaran R
J Geriatr Oncol; 2019 Jul; 10(4):523-525. PubMed ID: 30982753
[No Abstract] [Full Text] [Related]
10. Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice.
Bianconi M; Santoni M; Massari F; Faloppi L; Del Prete M; Giampieri R; Ciccarese C; Modena A; Tortora G; Scartozzi M; Cascinu S
Future Oncol; 2014 Nov; 10(14):2103-6. PubMed ID: 25471023
[TBL] [Abstract][Full Text] [Related]
11. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
Buti S; Ciccarese C; Iacovelli R; Bersanelli M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R; Tortora G; Massari F
Future Oncol; 2016 Sep; 12(17):1971-4. PubMed ID: 27312584
[TBL] [Abstract][Full Text] [Related]
12. Highlights from the 2023 American Society of Clinical Oncology Annual Meeting: genitourinary cancer.
George DJ
Clin Adv Hematol Oncol; 2023 Jul; 21(7):366-368. PubMed ID: 37477996
[No Abstract] [Full Text] [Related]
13. A medical oncologist's perspective on the treatment of patients with genitourinary malignancies.
Sternberg CN
Urol Oncol; 2009; 27(2):122-5. PubMed ID: 19285223
[No Abstract] [Full Text] [Related]
14. Highlights in advanced prostate cancer from the 2012 American Urological Association Annual Meeting and the 2012 American Society of Clinical Oncology Annual Meeting.
Shore ND
Clin Adv Hematol Oncol; 2012 Aug; 10(8 Suppl 12):1-24. PubMed ID: 23072827
[No Abstract] [Full Text] [Related]
15. The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group--a new co-operative cancer trials group in genitourinary oncology.
Sengupta S; Grimison P; Hayne D; Williams S; Chambers S; DeSouza P; Stockler M; McJannett M; Toner G; Davis ID
BJU Int; 2015 Jun; 115(6):856-8. PubMed ID: 25195815
[No Abstract] [Full Text] [Related]
16. Highlights from the 41st Annual Meeting of the American Society of Clinical Oncology, May 2005, and the 2005 American Society of Clinical Oncology Prostate Cancer Symposium, February 2005, Orlando, Florida.
Reddy GK; Tyagi P
Clin Prostate Cancer; 2005 Jun; 4(1):7-14. PubMed ID: 15992456
[No Abstract] [Full Text] [Related]
17. Re: Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.
da Silva FC; Algaba F
Eur Urol; 2021 Feb; 79(2):318-319. PubMed ID: 33218825
[No Abstract] [Full Text] [Related]
18. Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancer.
Iacovelli R; Santoni M; de Braud F; Cascinu S; Procopio G
Expert Rev Anticancer Ther; 2014 Dec; 14(12):1407-9. PubMed ID: 25159199
[TBL] [Abstract][Full Text] [Related]
19. 2011 ASCO Genitourinary Cancers Symposium.
Brierley R
Lancet Oncol; 2011 Apr; 12(4):330. PubMed ID: 21598448
[No Abstract] [Full Text] [Related]
20. Highlights in prostate cancer from the 2020 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2020 Sep; 18(9):520-521. PubMed ID: 33006580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
